Allegaert, K., Rayyan, M., Cossey, V., & Van Geet, C. (2015). Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 4(1), e040104. https://doi.org/10.7363/040104